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Purpose or Objective: To evaluate the feasibility and 
effectiveness of combining radiofrequency (RF), 
cementoplasty (CP) and Radiotherapy (RT) for pain treatment 
of bone metastasis (mts) in oligo-metastatic patients (pts). 
 
Material and Methods: From April 2015 to September 2015 
twelve pts. (9 men, 3 women; median age 64 years) with 12 
injuries to bones (vertebral column n = 9; femur, n = 1; 
sacrum, n = 2) were treated. Diagnosis of bone mts and then 
its treatment should be based on the combination of 
different elements: clinical evaluation, CT, MRI and nuclear 
medicine patterns. The mini-invasive treatment of oligo-
metastatic pts aims pain relief that improving the quality of 
life; treat biomechanical stability of the spine; and an 
antineoplastic effect - cytoreductive. RF ablation was 
performed with the pts under sedation a CT - guidance, and 
was followed by cement injection. Pain relief was valuated 
with visual analogue scale (VAS) score. After 10 days on 
average, the patient was subjected to Stereotactic-RT or 
Volumetric Modulated Arc Therapy (VMAT) technique and a 
total dose of 20-30 Gy. 
 
Results: Technical success and pain relief was archived in all 
pts. Pain rating with the VAS decrease from a mean of 9 to a 
mean of 4, and after 3 month was detected a mayor decrease 
(2,5). We recorded an overall improvement in the quality of 
life measured with a suitable test There was no particular 
toxicity. At present no patient died for progression of 
disease.The evolution of the disease will be evaluated with 
the use of MRI.  
 
Conclusion: Our data showing the importance of a multi-
disciplinary approach oligo-metastatic patients. RF with CP 
and RT carried out by experts is effective for pain relief and 
functional recovery in patients with painful bone metastases 
and can significantly improve quality of life. 
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Purpose or Objective: Few phase II trials have been 
performed to analyse the efficacy of post-operative 
stereotactic ablative radiotherapy (SABR) for brain 
metastases. The aim of the present study was to analyse 
outcome of this strategy in another cohort. 
 
Material and Methods: Between September 2011 and 
February 2015 a total of 49 patients (49 lesions) were treated 
and available for analysis. Eligibility criteria included 
histologically confirmed malignancy with 1 intra parenchymal 
brain metastase, age ≥18 years, Karnofsky performance 
status (KPS) ≥70 and controlled extracranial disease. Fourt y-
two patients have been treated with a single fraction of 18 
Gy, and 7 patients with 5 fractions of 5-7 Gy (median dose of 
31 Gy) if tumor size was more than 3 cm. SABR treatment 
was prescribed to the 80% isodose. Survival was evaluated 
with the Kaplan Meier method. 
 
Results: The median follow-up was 14 months (range, 2-45). 
SABR to the surgical bed was performed 41 days (13-105) 
after surgery. Overall, there were 8 local failures (LF) 
resulting in a 6 months, 1- and 2-year local control rates of 
97.9%, 86%, and 74.9%, respectively. The 1- and 2-year 
overall survival rates were 62.6% and 39%. The 6 months, 1- 
and 2-year encephalic control rates were 72.9%, 56.7%, and 
34.6%, respectively. The Biological Effective Dose, histology, 
and time interval between surgery and SABR did not correlate 
with LF in univariate analysis (p> 0.05, Log-Rank).Tumor 
maximal diameter >3 cm was associated with an increased 
rate of LF in comparison with smaller tumors (one-year rate 
LF of 30% vs 7.1%, p=0.02, Log-Rank). Seventy percent of 
patients died because of extra cranial disease progression 
while 30 % of patient because of intracranial disease 
progression. For 14patients with multiple recurrent brain 
metastases, the whole brain radiotherapy was performed 294 
days (126-812) after SABR. 
 
Conclusion: In this cohort postoperative SABR was associated 
with high rates of local control and encephalic tumor control, 
especially for brain metastases <3 cm. 
 
EP-1439  
Percutaneous pedicle screw fixation for the treatment of 
unstable spinal metastases 
J.J. Verlaan
1University Medical Center Utrecht, Orthopedics, Utrecht, 
The Netherlands 
1, A.L. Versteeg1, P. De Baat2, T. Jiya3, C.H. 
Diekerhof4, G. Van Solinge5, F.C. Oner1 
2Catharina Hospital, Orthopedics, Eindhoven, The 
Netherlands 
3VU University Medical Center, Orthopedics, Amsterdam, The 
Netherlands 
4St. Elisabeth Hospital, Orthopedics, Tilburg, The 
Netherlands 
5Isala Clinics, Orthopedics, Zwolle, The Netherlands 
 
Purpose or Objective: Unstable spinal metastases require 
surgical stabilization often followed by radiotherapy for local 
tumor control. However, surgical stabilization and 
radiotherapy are not very compatible treatment modalities. 
A frequent complication of surgical stabilization after 
irradiation is disturbed wound healing which can have a 
devastating impact on quality of life. Advancements in 
surgical techniques has led to the development of less 
invasive surgical (LIS) procedures. LIS procedures aim to 
achieve similar clinical outcomes, as compared with open 
procedures, but with less approach related morbidity. 
Additionally, improved wound healing after LIS procedures 
may allow earlier administration of adjuvant treatments. 
However, little is known concerning the complications after 
LIS procedures for the treatment of spinal metastases. 
Therefore the aim of this study was to determine the 
incidence and characteristics of complications after 
percutaneous pedicle screw fixation (PPSF) for the treatment 
of unstable spinal metastases. 
 
Material and Methods: An ambispective multicentre cohort 
study of patients who underwent PPSF between 2009 and 
2014 for the treatment of unstable spinal metastases was 
performed. Data regarding demographics, tumor histology, 
surgical treatment, neurological status, complications and 
survival were systematically collected. 
 
Results: A total of 101 patients were identified, 45 males and 
56 females with a mean age of 60.3 years (± 11.2). The most 
common primary tumors (in hierarchical order) were breast 
cancer (25%), multiple myeloma (25%), lung cancer (13%) and 
renal cell carcinoma (10%). Ninety-three per cent of the 
patients were neurologically intact at the time of surgery. 
The median operating time was 122 minutes (range 55 – 325) 
with a median blood loss of 100 ml (N=41). The overall 
median survival was 11.0 months (range 0-70 months) with 79 
(78%) patients being alive three months postoperative. 
Eighty-seven per cent of the patients was ambulatory within 
three days postoperative. A total of 30 complications 
occurred in 18 patients. Non-surgical adverse events (9%) 
were most commonly encountered. Wound complications 
occurred in 4 patients, including 2 deep wound infections 
with one requiring surgical debridement. Prolonged operating 
was associated with increased risk of post-operative 
complications (P=0.041). No relation between the 
administration of pre- or postoperative radiotherapy and the 
occurrence of complications could be determined. 
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Conclusion: A complication rate of 18% was found after less 
invasive surgery for the treatment of spinal metastases. 
Promising clinical outcomes were demonstrated in terms of 
minimal blood loss, high rates of early post-operative 
ambulation and few wound complications, which may allow 
earlier administration of adjuvant oncological treatments. 
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Purpose or Objective: Functional evaluation is crucial in the 
approach of patients, and the most commonly used 
functional evaluation tool in cancer patients has been the 
Karnofsky Scale (KS). A KPS of less than 50% suggests a high 
mortality risk within 6 months. The Tokuhashi scoring system 
(TS) is a survival prediction in patients with spinal metastasis. 
For patients with total TS of 8 or less points, TS predicts a 
survival of 6 months or less. This study aims to compare KPS 
and TS for life expectancy in palliative patients with spinal 
cord compression. 
 
Material and Methods: A sample of 79 patients with cord 
compression diagnosed from 2007 to 2014 was obtained by 
consecutive sampling, and KPS and TS were calculated for 
each patient. The analysis was performed retrospectively, 
with survival data registered until October 2014. Percentage 
of patients with KPS ≤ 50% and TS ≤ 8 are shown and 
compared with the survival percentage.  
 
Results: With an average follow up of 4 months (range 0-45), 
52.5% of the sample showed KPS ≤ 50% and 80.8% TS ≤ 8. At 
dead line, 10.3 % continued walking, 2.6 % needed 
wheelchair, 48.7 % died and 38.5 % were lost in follow up. 
For patients with follow up, 90% with TS ≤ 8 livedless than 6 
months and 90% of patients with KPS ≤ 50% lived less than 6 
months. 
 
Conclusion: Both prognostic scoring systems show similar 
survival rates in groups KPS≤50% and TS≤ 8%, adding evidence 
to the Tokuhashi scale as a predictor of survival. 
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Purpose or Objective: To investigate the feasibility, the 
tolerability and the impact of comorbidity assessment on the 
compliance of adjuvant Intensity Modulated Radiation 
Therapy (IMRT) and simultaneous integrated boost (SIB) in 
elderly patients with a diagnosis of breast cancer after 
breast-conserving surgery (BCS). 
 
Material and Methods: Between 09/2011 to 02/2014, 40 
consecutive women with a diagnosis of early stage breast 
cancer were treated with SIB-IMRT after BCS in our 
Institution. Inclusion criteria were: age ≥ 70 years, pT1 -2 
disease, pN0-1, no neoadjuvant chemotherapy, non-
metastatic disease. A dose prescription of 50 Gy in 25 
fractions was prescribed to the whole breast (PTVbreast) and 
an additional dose of radiation on the tumour bed was 
prescribed (PTVboost). A dose prescription of 60 Gy in 25 
fractions to PTVboost was used in patients with negative 
margins after surgery, whereas if the margins were close (< 1 
mm) or positive (without a new surgical resection) a dose of 
64 Gy was prescribed. Charlson Comorbidity Index (CCI) was 
used for comorbidity scoring. All patients were followed with 
periodic clinical evaluation. Acute and late toxicity were 
scored using the EORTC/RTOG radiation morbidity score 
system. Both patient and physician recorded cosmetic 
outcome evaluation with a subjective judgment scale at the 
time of scheduled follow-up. 
 
Results: Median follow-up was 36 months. At the time of the 
analysis, OS and LC rates were 100%. All patients completed 
the SIB-IMRT without interruptions. Acute skin toxicity was 
recorded as follow: grade 0 in 5 patients (12.5%), grade 1 in 
25 cases (62.5%), grade 2 in 10 patients (25%). Regarding late 
adverse events, skin toxicity was registered as follow: grade 
0 in 27 patients (67.5%), grade 1 in 13 cases (32.5%). No 
toxicity ≥ grade 2 was registered. At statistical analysis, the 
presence of comorbidities and the breast volume > 700cc 
were related to skin grade 2 acute toxicity (p=0.01, p=0.04). 
In terms of cosmetic results, 98% and 2%of patients 
considered the result as good /excellent and as fair after RT, 
respectively. No patients had a poor cosmetic outcome. 
 
Conclusion: These data support the feasibility and safety of 
SIB-IMRT in elderly patients with a diagnosis of breast cancer 
following BCS with acceptable acute and late treatment-
related toxicity. Moreover, the absence of comorbidity 
reduced the risk of acute radiation side effects. 
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Purpose or Objective: To report about clinical outcome of 
stereotactic body radiation therapy (SBRT) in the treatment 
of oligometastatic disease in elderly patients affected by 
colorectal cancer. 
 
Material and Methods: Patients with 1–4 inoperable 
metastases were treated with SBRT. Dose prescription ranged 
from 40 to 75Gy in 3–8 fractions. SBRT was delivered using 
the volumetric modulated arc therapy technique with 
flattening filter-free photon beams. The primary end points 
were in-field local control (LC) and toxicity. Secondary end 
points was overall survival (OS). 
 
Results: 52 patients with 57 total metastases were treated. 
Mean age was 79.85 years (range 73.57-88.56). 47 patients 
(90.4%) had a single lesion; the remaining had 2 lesions. 34 
lesions (59.6%) were located in the liver, 18 (31.6%) in the 
lungs and the remaining 5 (8.8%) were nodal or adrenal 
metastases. Local response was observed for 35 lesions 
(61.4%), with 19 complete responses and 16 partial 
responses, while local progression in 18 lesions (31.6%); 
stable disease was recorded in 4 cases (7%). Actuarial 1, 2 
and 3 year LC was 92%, 78 % and 71%. At time of analysis, 
with a mean follow up of 2.2 years (range 0.2-4.9), 38 
patients (73,1%) were still alive, while 14 (26.9%) died (11 
patients died for disease progression). Actuarial 1, 2 and 3 
year OS were 98%, 89% and 61,1% respectively. Treatment-
related Grade 2 toxicity was observed in two patients (3.8%); 
Grade 1 toxicity in five patients (9.6%) and no toxicity was 
observed in 86.6% of the cases. No G3-4 toxicity was 
recorded. 
 
Conclusion: SBRT is a safe and effective therapeutic option 
for the treatment of oligometastatic disease in the elderly 
affected by colorectal cancer with acceptable rates of LC and 
low treatment related toxicity. The use of SBRT for 
oligometastatic disease in the elderly can be considered as a 
valuable approach, particularly for patients with fragile 
status or refusing other approaches. 
 
 
 
 
